Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate by Marcelo Antonio de Oliveira, Gerliane Damázio da Silva, Michele Soares Tacchi Campos

Subjects: “…Hypertriglyceridemia/fibrates…”
Get full text

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention by Zhou Yu-Hao, Ye Xiao-Fei, Yu Fei-Fei, Zhang Xiao, Qin Ying-Yi, Lu Jian, He Jia

Subjects: “…Fibrates…”
Get full text

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT by I. V. Shirinskiy, O. A. Polovnikova, V. S. Shirinskiy

Subjects: Get full text

Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study by Amanda J. Berberich, Alexandra M. Ouédraogo, Salimah Z. Shariff, Robert A. Hegele, Kristin K. Clemens

Subjects: Get full text

Associação de medicamentos: estatinas e fibratos Combination of drugs: statins and fibrates by Hermes Toros Xavier

Subjects: Get full text

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities by Watts Gerald F

Subjects: “…fibrates…”
Get full text

Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis by Lise Van Wyngene, Tineke Vanderhaeghen, Steven Timmermans, Jolien Vandewalle, Kelly Van Looveren, Jolien Souffriau, Charlotte Wallaeys, Melanie Eggermont, Sam Ernst, Evelien Van Hamme, Amanda Gonçalves, Guy Eelen, Anneleen Remmerie, Charlotte L Scott, Caroline Rombouts, Lynn Vanhaecke, Liesbet De Bus, Johan Decruyenaere, Peter Carmeliet, Claude Libert

Subjects: “…fibrates…”
Get full text

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body... by Medel Octavio, Hernández Ismael, Salinas Saul, Vazquez Cuauhtémoc, Ramírez Erika, Jiménez Sergio, Hernández Ma, Florenzano Fernando, Saavedra Victor, Reyes Eliana, Machado Carlos, Oliveira José, Torres Kerginaldo, Rabelo Lísia, Neto Abrahão, Filho José, Rengifo Hector, Stockins Benjamín, Aguilar-Salinas Carlos A, Assis-Luores-Vale Andréia, Moreno Ricardo, Lugo Paula, Alvarado Ricardo, Mehta Roopa, Gutierrez Victor, Gómez Pérez Francisco J

Subjects: Get full text

Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study by Francis Gordon A, Frohlich Jiri, Taraboanta Catalin, Al-Sarraf Ahmad, Sandhu Supna

Subjects: Get full text

Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of Candida glabrata (CgHMGR), Thus Decreasin... by Damián A. Madrigal-Aguilar, Adilene Gonzalez-Silva, Blanca Rosales-Acosta, Celia Bautista-Crescencio, Jossué Ortiz-Álvarez, Carlos H. Escalante, Jaime Sánchez-Navarrete, César Hernández-Rodríguez, Germán Chamorro-Cevallos, Joaquín Tamariz, Lourdes Villa-Tanaca

Subjects: Get full text

Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients by L. A. Ratnikova, V. A. Metelskaya, M. N. Mamedov, O. V. Kosmatova, N. V. Perova

Subjects: Get full text

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both? by Tenenbaum Alexander, Fisman Enrique Z

Subjects: Get full text

Comparative analysis of the use of lipid modifying agents in the Republic of Serbia and Nordic countries in the period 2015-2017 by Martić Nikola B., Zečević Dragan D., Đurđević Milena V., Milijašević Dragana S., Tomić Nataša Z., Lalić-Popović Mladena N., Todorović Nemanja B., Medin Danilo V., Mićanović Branimir B., Milijašević Boris Ž.

Subjects: Get full text

Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet by Ying Zhang, Xiu-Bin Jia, Yun-Chao Liu, Wen-Qian Yu, Yan-Hong Si, Yan-Hong Si, Shou-Dong Guo

Subjects: Get full text

New approaches to triglyceride reduction: Is there any hope left? by Annalisa Filtz, Siddhant Parihar, Garred S. Greenberg, Christine M. Park, Andrea Scotti, Daniel Lorenzatti, Juan J Badimon, Daniel E. Soffer, Peter P. Toth, Carl J. Lavie, Vera Bittner, Salim S. Virani, Leandro Slipczuk

Subjects: Get full text

Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells by Viralkumar Davra, Kenza E. Benzeroual

Subjects: Get full text

Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study by Mohammadreza Bordbar, Renée de Mutsert, Melike Cevval, Frits R. Rosendaal, J. Wouter Jukema, Willem M. Lijfering

Subjects: Get full text

Fibrates for Primary Biliary Cholangitis: What’s All the Hype? by Cynthia Levy

Subjects: Get full text

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia by Ariel Brautbar, Salim S. Virani, John Belmont, Vijay Nambi, Peter H. Jones, Christie M. Ballantyne

Subjects: Get full text

Hydrogen sulfide donor-based fibrates: Design, synthesis, and evaluation for hypolipidemic activity and hepatoprotection by Wenhua Sun, Shipeng He, Yundong Xie, Yong Quan

Subjects: “…Hydrogen sulfide-based fibrates…”
Get full text